bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium

Author's Avatar
Apr 25, 2023

bioAffinity+Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer, will present at the Cleveland Clinic’s invitation-only Advances in Early Lung Cancer Detection annual symposium in Cleveland, Ohio, on April 27, 2023.